A kind of method for measuring the concentration of sclareol in plasma

A technology for sclareol and plasma, which is applied in measuring devices, instruments, scientific instruments, etc., to achieve the effects of short time, strong specificity and small sample consumption

Inactive Publication Date: 2016-03-16
WUXI PEOPLES HOSPITAL
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, there is no literature report on the blood drug concentration detection method of sclareol. The present invention establishes the determination method of sclareol in rat plasma for the first time, and explores the drug metabolism of sclareol by this method Sexual research, laying a solid methodological foundation for its preclinical pharmacokinetic research

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of method for measuring the concentration of sclareol in plasma
  • A kind of method for measuring the concentration of sclareol in plasma
  • A kind of method for measuring the concentration of sclareol in plasma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0026] Example: Determination of Sclareol Concentration in Rat Plasma

[0027] Experimental Materials and Instruments

[0028] Sclareol: purity>98%, batch number: MUST-14072810, purchased from Chengdu Mansite Biotechnology Co., Ltd.; internal standard: nitroazepam, batch number: 9201, purchased from the National Narcotics Laboratory; methanol (CNW company ), batch number: HX080973; ammonium acetate (Sinopharm Chemical Reagent Co., Ltd.), batch number: F20090520; water was made by ultrapure water (Milli-Q pure water machine).

[0029] Liquid chromatography system: ACCELAautosampler, ACCELA1250pump, American ThermoFisher Company; MS / MS system: TSQQuantumAccess triple quadrupole tandem mass spectrometer, equipped with electrospray ionization ESI ion source, American ThermoFisher Company; data acquisition: LCQUAN TM 2.6 software, American ThermoFisher company; XW-80A miniature vortex mixer, Shanghai Medical University Instrument Factory; Z233MK-2 high-speed centrifuge, German HER...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
lengthaaaaaaaaaa
particle diameteraaaaaaaaaa
Login to view more

Abstract

The invention relates to a method for determining concentration of sclareol in blood plasma and belongs to the technical field of biological detection. Nitrazepam is taken as an internal standard, a protein precipitation method is adopted, and the concentration of sclareol in the determined blood plasma is calculated by virtue of blood plasma sample pre-treatment, chromatograph, mass spectrometry and an internal standard method. The method for determining the concentration of sclareol in the blood plasma is rapid, accurate, high in sensitivity and easy to operate, and a methodological foundation is laid for drug metabolism dynamic research of sclareol in an animal body.

Description

technical field [0001] The invention relates to a method for measuring the concentration of sclareol in blood plasma, belonging to the technical field of biological detection. Background technique [0002] Sclareol (sclareol), also known as hard tail alcohol, is a ditertiary alcohol compound of the diterpenoid ditertiary alcohol isolated from Clary perilla, tobacco and other Salvia genus Labiatae plants. In vivo and in vitro studies have confirmed that it has anti-inflammatory, antibacterial, and bactericidal effects, and has varying degrees of killing effects on malignant tumor cells such as human leukemia cells, human colon cancer cells, and human breast cancer cells. It is a promising development prospect. New drug source compounds. Its structural formula is as follows: [0003] [0004] At present, there is no literature report on the blood drug concentration detection method of sclareol. The present invention establishes the determination method of sclareol in rat ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): G01N30/02
Inventor 黄凯张娜贺晴
Owner WUXI PEOPLES HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products